SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-014500
Filing Date
2022-03-23
Accepted
2022-03-23 16:29:41
Documents
1
Period of Report
2022-03-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4080
  Complete submission text file 0001213900-22-014500.txt   5423
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Issuer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 325 N. LARCHMONT BLVD, SUITE 375 LOS ANGELES CA 90004
Business Address
Juda Scott (Reporting) CIK: 0001767084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38793 | Film No.: 22763536